Human schistosomiasis

Lancet. 2014 Jun 28;383(9936):2253-64. doi: 10.1016/S0140-6736(13)61949-2. Epub 2014 Apr 1.

Abstract

Human schistosomiasis--or bilharzia--is a parasitic disease caused by trematode flukes of the genus Schistosoma. By conservative estimates, at least 230 million people worldwide are infected with Schistosoma spp. Adult schistosome worms colonise human blood vessels for years, successfully evading the immune system while excreting hundreds to thousands of eggs daily, which must either leave the body in excreta or become trapped in nearby tissues. Trapped eggs induce a distinct immune-mediated granulomatous response that causes local and systemic pathological effects ranging from anaemia, growth stunting, impaired cognition, and decreased physical fitness, to organ-specific effects such as severe hepatosplenism, periportal fibrosis with portal hypertension, and urogenital inflammation and scarring. At present, preventive public health measures in endemic regions consist of treatment once every 1 or 2 years with the isoquinolinone drug, praziquantel, to suppress morbidity. In some locations, elimination of transmission is now the goal; however, more sensitive diagnostics are needed in both the field and clinics, and integrated environmental and health-care management will be needed to ensure elimination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Animals
  • Child
  • Child, Preschool
  • Communicable Disease Control / methods
  • Cost of Illness
  • Female
  • Global Health
  • Humans
  • Immunity, Cellular
  • Infant
  • Life Cycle Stages / physiology
  • Male
  • Middle Aged
  • Parasite Egg Count
  • Schistosoma / growth & development
  • Schistosomiasis / diagnosis
  • Schistosomiasis / epidemiology
  • Schistosomiasis / prevention & control*
  • Schistosomicides / therapeutic use*
  • Young Adult

Substances

  • Schistosomicides